18.12.2012 Views

2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

SURVEILLANCE FOLLOWING BREAST CANCER DIAGNOSIS<br />

cells in the ducts, with subsequent developing ductal microcalcifications.<br />

Some centers advocate a postsurgical, preradiation<br />

therapy mammogram <strong>of</strong> the treated side as a<br />

baseline for just this purpose.<br />

In general, calcifications developing in the first 2 years are<br />

dystrophic and thereafter are more likely as a result <strong>of</strong><br />

recurrent disease.<br />

For palpable findings, targeted breast US is the initial<br />

imaging modality <strong>of</strong> choice. Findings are usually related to<br />

scarring or to a lump caused by development <strong>of</strong> fat necrosis.<br />

Imaging Appearances <strong>of</strong> Recurrent Disease<br />

Table 1. Examples <strong>of</strong> Breast Conservation Surveillance Protocol by Institution<br />

Institution Mammography Physical Examination<br />

M. D. Anderson Cancer Center At 6 mo, then annual diagnostic for 5 yr; screening from year 6 Every 6 mo for 5 yr, then annual<br />

University <strong>of</strong> California, San Francisco Every 6 mo for 5 yr, then annual screening Every 6 mo for 5 yr, then annual<br />

University <strong>of</strong> California, Los Angelas Every 6 mo for 2 yr, then annual diagnostic Left to primary care<br />

M<strong>of</strong>fitt Cancer Center Every 6 mo for 2 yr, then annual diagnostic until yr 10 Every 6 mo for 5 yr, then annual<br />

Brigham and Women’s Hospital and<br />

Dana-Farber Cancer Center<br />

At 6 mo after completion <strong>of</strong> radiotherapy, then annual diagnostic Every 6 mo for 5 yr<br />

Abbreviations: mo, months; yr, years.<br />

In general, a recurrent cancer shows similar appearances<br />

to the original malignancy, such that a patient with DCIS<br />

will have developing microcalcifications in the treated breast,<br />

and high-grade tumors with DCIS may present as a developing<br />

focal asymmetry containing calcifications (Fig. 1).<br />

Fig. 1. Example <strong>of</strong> recurrent DCIS with a sharp margin corresponding<br />

to the edge <strong>of</strong> the radiotherapy boost site.<br />

Abbreviation: DCIS, ductal carcinoma in situ.<br />

We recommend that spot magnification views be part <strong>of</strong><br />

the initial post-lumpectomy mammogram for patients in<br />

whom calcified DCIS is present, whether invasive or in situ.<br />

This will act as the new baseline exam for comparison.<br />

Developing microcalcifications usually ring alarm bells but<br />

can be commonly seen in patients prone to developing fat<br />

necrosis.<br />

Special types <strong>of</strong> tumors, such as angiosarcomas, require<br />

more specialized follow-up, which can be a combination <strong>of</strong><br />

Doppler US and MRI. The permeative vascular nature <strong>of</strong> the<br />

recurrent tumor is best seen on MRI (Fig. 2).<br />

Mastectomy without Reconstruction<br />

A patient who has been treated by mastectomy has a<br />

contralateral breast cancer risk <strong>of</strong> approximately 7%, and so<br />

surveillance <strong>of</strong> the treated breast is almost entirely covered<br />

by physical examination, with targeted US scan <strong>of</strong> any<br />

palpable area. The contralateral breast will continue to be<br />

monitored by a regular annual mammographic examination,<br />

with additional imaging being reserved for patients who are<br />

symptomatic or who have a palpable finding.<br />

Male Survivors <strong>of</strong> Breast Cancer<br />

These are the forgotten survivors <strong>of</strong> cancer. The surveillance<br />

protocol for a male patient should be the same as that<br />

for a woman who has had a mastectomy without reconstruction.<br />

Most recurrences in men should be palpable, hence the<br />

importance <strong>of</strong> a regular physical exam, and possibly “breast<br />

awareness” on the part <strong>of</strong> the man. If the patient has had a<br />

Fig. 2. MRI image showing enhancing nodule adjacent to seroma/<br />

lumpectomy site. Patient is 5 years post-surgery and 2 months<br />

post-completion <strong>of</strong> 5 years <strong>of</strong> tamoxifen.<br />

Abbreviation: MRI, magnetic resonance imaging.<br />

61

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!